Atlas Trials

TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation

Clinical trial NCT04677088 · UNKNOWN

Trial details

NCT number
NCT04677088
Sponsor
Xiaoshun He
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Hepatocellular Carcinoma
Start date
2018-03-29
Primary completion
2020-02-18
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.